Journal of Clinical Oncology, Vol 10, 1390-1396, Copyright © 1992 by American Society of Clinical Oncology

ARTICLES

Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score

JH Silber, J Radcliffe, V Peckham, G Perilongo, P Kishnani, M Fridman, JW Goldwein and AT Meadows
Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia.

PURPOSE: Decline in intelligence can occur after whole-brain cranial irradiation for childhood malignancy. The purpose of this analysis was to estimate better the impact of dose and age at time of irradiation on IQ decline. PATIENTS AND METHODS: A total of 48 children were studied. We combined two previously reported studies that included 15 patients with pediatric acute lymphocytic leukemia (ALL) and 18 pediatric patients with medulloblastoma/posterior fossa primitive neural ectodermal tumors (PNETs) in whom serial IQ tests were administered. Another 15 patients (nine ALL and six PNET) were studied subsequent to these reports. This experience included ALL patients who were treated with whole-brain irradiation at doses of 18 Gy (n = 9) and 24 Gy (n = 15), and PNET patients who were treated with 18 Gy (n = 5), 22 to 24 Gy (n = 2), and 32 to 40 Gy (n = 17). Multiple regression models were constructed to estimate expected IQ score after treatment based on initial IQ score, age at treatment, and dose of whole-brain irradiation. RESULTS: Using a multiple linear regression model to correct for initial IQ and age at treatment, patients who received a dose of 36 Gy to the whole brain were estimated to score 8.2 points less on IQ testing than those with 24 Gy (95% confidence interval [CI], 1.8 to 14.6) and 12.3 points less than those who received 18 Gy (95% CI, 2.7 to 21.7). Older age at the time of irradiation resulted in less decline in subsequent IQ score. The predicted IQ decline is 11.9 points less in a 10-year-old patient than in a 3-year-old patient (95% CI, 4.2 to 19.6) for equivalent doses of irradiation. The model to predict IQ accounts for half the total variation in IQ score. There was no significant difference between the coefficients that reflected IQ decrease from radiation dose between subgroups who had ALL versus those with PNET. CONCLUSIONS: One can forecast final IQ score based on the initial IQ score, dose of irradiation, and age at time of irradiation. Our findings should aid in the selection of appropriate therapy when whole-brain irradiation is needed.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. J. Sievert and M. J. Fisher Pediatric Low-Grade Gliomas J Child Neurol, November 1, 2009; 24(11): 1397 - 1408. [Abstract] [PDF]

				L. A. Jacobs, S. C. Palmer, L. A. Schwartz, A. DeMichele, J. J. Mao, J. Carver, C. Gracia, C. E. Hill-Kayser, J. M. Metz, M. K. Hampshire, et al. Adult Cancer Survivorship: Evolution, Research, and Planning Care CA Cancer J Clin, November 1, 2009; 59(6): 391 - 410. [Abstract] [Full Text] [PDF]

				B Pizer and S Clifford Medulloblastoma: new insights into biology and treatment Arch. Dis. Child. Ed. Pract., October 1, 2008; 93(5): 137 - 144. [Full Text] [PDF]

				N. G. Gottardo and A. Gajjar Chemotherapy for Malignant Brain Tumors of Childhood J Child Neurol, October 1, 2008; 23(10): 1149 - 1159. [Abstract] [PDF]

				G. T. Armstrong, C. A. Sklar, M. M. Hudson, and L. L. Robison Long-Term Health Status Among Survivors of Childhood Cancer: Does Sex Matter? J. Clin. Oncol., October 1, 2007; 25(28): 4477 - 4489. [Abstract] [Full Text] [PDF]

				B. P. Daly and R. T. Brown Scholarly Literature Review: Management of Neurocognitive Late Effects with Stimulant Medication J. Pediatr. Psychol., October 1, 2007; 32(9): 1111 - 1126. [Abstract] [Full Text] [PDF]

				P. M. Lahteenmaki, A. Harila-Saari, E. I. Pukkala, P. Kyyronen, T. T. Salmi, and R. Sankila Scholastic achievements of children with brain tumors at the end of comprehensive education: A nationwide, register-based study Neurology, July 17, 2007; 69(3): 296 - 305. [Abstract] [Full Text] [PDF]

				E. N. Kiehna, R. K. Mulhern, C. Li, X. Xiong, and T. E. Merchant Changes in Attentional Performance of Children and Young Adults With Localized Primary Brain Tumors After Conformal Radiation Therapy J. Clin. Oncol., November 20, 2006; 24(33): 5283 - 5290. [Abstract] [Full Text] [PDF]

				A. T. Meadows Pediatric Cancer Survivorship: Research and Clinical Care J. Clin. Oncol., November 10, 2006; 24(32): 5160 - 5165. [Abstract] [Full Text] [PDF]

				C. B. Reeves, S. L. Palmer, W. E. Reddick, T. E. Merchant, G. M. Buchanan, A. Gajjar, and R. K. Mulhern Attention and Memory Functioning Among Pediatric Patients with Medulloblastoma J. Pediatr. Psychol., April 1, 2006; 31(3): 272 - 280. [Abstract] [Full Text] [PDF]

				P.-L. Khong, L. H. T. Leung, G. C. F. Chan, D. L. W. Kwong, W. H. S. Wong, G. Cao, and G.-C. Ooi White Matter Anisotropy in Childhood Medulloblastoma Survivors: Association with Neurotoxicity Risk Factors Radiology, August 1, 2005; 236(2): 647 - 652. [Abstract] [Full Text] [PDF]

				J. Konczak, B. Schoch, A. Dimitrova, E. Gizewski, and D. Timmann Functional recovery of children and adolescents after cerebellar tumour resection Brain, June 1, 2005; 128(6): 1428 - 1441. [Abstract] [Full Text] [PDF]

				S. N. Chi, S. L. Gardner, A. S. Levy, E. A. Knopp, D. C. Miller, J. H. Wisoff, H. L. Weiner, and J. L. Finlay Feasibility and Response to Induction Chemotherapy Intensified With High-Dose Methotrexate for Young Children With Newly Diagnosed High-Risk Disseminated Medulloblastoma J. Clin. Oncol., December 15, 2004; 22(24): 4881 - 4887. [Abstract] [Full Text] [PDF]

				K. C. Oeffinger and M. M. Hudson Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors CA Cancer J Clin, July 1, 2004; 54(4): 208 - 236. [Abstract] [Full Text] [PDF]

				A. Gajjar, R. Hernan, M. Kocak, C. Fuller, Y. Lee, P. J. McKinnon, D. Wallace, C. Lau, M. Chintagumpala, D. M. Ashley, et al. Clinical, Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease Risk Stratification System for Medulloblastoma J. Clin. Oncol., March 15, 2004; 22(6): 984 - 993. [Abstract] [Full Text] [PDF]

				E. T. Wong and A. Berkenblit The Role of Topotecan in the Treatment of Brain Metastases Oncologist, February 1, 2004; 9(1): 68 - 79. [Abstract] [Full Text] [PDF]

				M. Clarke, P. Gaynon, I. Hann, G. Harrison, G. Masera, R. Peto, and S. Richards CNS-Directed Therapy for Childhood Acute Lymphoblastic Leukemia: Childhood ALL Collaborative Group Overview of 43 Randomized Trials J. Clin. Oncol., May 1, 2003; 21(9): 1798 - 1809. [Abstract] [Full Text] [PDF]

				B. Timmermann, R.-D. Kortmann, J. Kuhl, C. Meisner, K. Dieckmann, T. Pietsch, and M. Bamberg Role of Radiotherapy in the Treatment of Supratentorial Primitive Neuroectodermal Tumors in Childhood: Results of the Prospective German Brain Tumor Trials HIT 88/89 and 91 J. Clin. Oncol., February 1, 2002; 20(3): 842 - 849. [Abstract] [Full Text] [PDF]

				H. Aoyama, H. Shirato, J. Ikeda, K. Fujieda, K. Miyasaka, and Y. Sawamura Induction Chemotherapy Followed by Low-Dose Involved-Field Radiotherapy for Intracranial Germ Cell Tumors J. Clin. Oncol., February 1, 2002; 20(3): 857 - 865. [Abstract] [Full Text] [PDF]

				M. D. Ris, R. Packer, J. Goldwein, D. Jones-Wallace, and J. M. Boyett Intellectual Outcome After Reduced-Dose Radiation Therapy Plus Adjuvant Chemotherapy for Medulloblastoma: A Children's Cancer Group Study J. Clin. Oncol., August 1, 2001; 19(15): 3470 - 3476. [Abstract] [Full Text] [PDF]

				M. A. Grotzer, M. D. Hogarty, A. J. Janss, X. Liu, H. Zhao, A. Eggert, L. N. Sutton, L. B. Rorke, G. M. Brodeur, and P. C. Phillips MYC Messenger RNA Expression Predicts Survival Outcome in Childhood Primitive Neuroectodermal Tumor/Medulloblastoma Clin. Cancer Res., August 1, 2001; 7(8): 2425 - 2433. [Abstract] [Full Text] [PDF]

				S. A. Sands, S. J. Kellie, A. L. Davidow, B. Diez, J. Villablanca, H. L. Weiner, M. C. Pietanza, C. Balmaceda, and J. L. Finlay Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: From the First International CNS Germ-Cell Tumor Study Neuro-oncol, July 1, 2001; 3(3): 174 - 183. [Abstract] [PDF]

				L. Horvath, D. McDowell, G. Stevens, R. Parkinson, S. McCarthy, and M. Boyer Unusual Presentations of Germ Cell Tumors: Case 2. Seminoma of the Conus Medullaris J. Clin. Oncol., February 1, 2001; 19(3): 911 - 915. [Full Text]

				R. K. Mulhern, S. L. Palmer, W. E. Reddick, J. O. Glass, L. E. Kun, J. Taylor, J. Langston, and A. Gajjar Risks of Young Age for Selected Neurocognitive Deficits in Medulloblastoma Are Associated With White Matter Loss J. Clin. Oncol., January 15, 2001; 19(2): 472 - 479. [Abstract] [Full Text] [PDF]

				S M Yule, T A H Hide, M Cranney, E Simpson, and A Barrett Low grade astrocytomas in the West of Scotland 1987-96: treatment, outcome, and cognitive functioning Arch. Dis. Child., January 1, 2001; 84(1): 61 - 64. [Abstract] [Full Text]

				M. A. Grotzer, A. J. Janss, K.-M. Fung, J. A. Biegel, L. N. Sutton, L. B. Rorke, H. Zhao, A. Cnaan, P. C. Phillips, V. M.-Y. Lee, et al. TrkC Expression Predicts Good Clinical Outcome in Primitive Neuroectodermal Brain Tumors J. Clin. Oncol., March 1, 2000; 18(5): 1027 - 1027. [Abstract] [Full Text] [PDF]

				M. Fouladi, J. Langston, R. Mulhern, D. Jones, X. Xiong, J. Yang, S. Thompson, A. Walter, R. Heideman, L. Kun, et al. Silent Lacunar Lesions Detected by Magnetic Resonance Imaging of Children With Brain Tumors: A Late Sequela of Therapy J. Clin. Oncol., February 14, 2000; 18(4): 824 - 824. [Abstract] [Full Text] [PDF]

				F Craig, A D Leiper, R Stanhope, C Brain, S T Meller, and S S Nussey Sexually dimorphic and radiation dose dependent effect of cranial irradiation on body mass index Arch. Dis. Child., December 1, 1999; 81(6): 500 - 504. [Abstract] [Full Text]

				D. R. Copeland, C. deMoor, B. D. Moore III, and J. L. Ater Neurocognitive Development of Children After a Cerebellar Tumor in Infancy: A Longitudinal Study J. Clin. Oncol., November 1, 1999; 17(11): 3476 - 3486. [Abstract] [Full Text] [PDF]

				M. Bamberg, R.-D. Kortmann, G. Calaminus, G. Becker, C. Meisner, D. Harms, and U. Gobel Radiation Therapy for Intracranial Germinoma: Results of the German Cooperative Prospective Trials MAKEI 83/86/89 J. Clin. Oncol., August 1, 1999; 17(8): 2585 - 2585. [Abstract] [Full Text] [PDF]

				M. D. Weil, K. Lamborn, M. S. B. Edwards, and W. M. Wara Influence of a Child's Sex on Medulloblastoma Outcome JAMA, May 13, 1998; 279(18): 1474 - 1476. [Abstract] [Full Text] [PDF]

				M. C. Chamberlain Recurrent Cerebellar Gliomas: Salvage Therapy With Oral Etoposide J Child Neurol, April 1, 1997; 12(3): 200 - 204. [Abstract] [PDF]

				R. Haupt, T. R. Fears, L. L. Robison, J. L. Mills, H. S. Nicholson, L. K. Zeltzer, A. T. Meadows, and J. Byrne Educational Attainment in Long-term Survivors of Childhood Acute Lymphoblastic Leukemia JAMA, November 9, 1994; 272(18): 1427 - 1432. [Abstract] [PDF]

				PREDICTING THE IMPACT OF BRAIN IRRADIATION ON CHILDREN'S IQ Journal Watch (General), October 6, 1992; 1992(1006): 6 - 6. [Full Text]